Primary dressing for slow drainage wounds such as surgical sites, skin tears or poorly draining wounds. Indicated to cover a wound, give or withstand a moist wound environment, and allow the exchange of gases such as oxygen and water vapor to through the device. Surgical incisions, lacerations, central and peripheral line sites, pressure ulcers, stasis ulcers, arterial ulcers, diabetic ulcers, abrasions and donor areas. Lacerations or eye injuries. Used to absorb fluids and secretions in procedures such as postalaparotomy, tumors, infected wounds, chronic wounds, wounds with high exudate and premature rupture of membranes, among others. Primary dressing in arms and legs, secondary dressing in abdomen.
“If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.